期刊文献+

细胞因子对肾癌细胞株786-0、GRC-1 Fas、FasL表达的调节及其意义 被引量:2

Expression and implication of Fas and FasL modulate by cytokines in renal cell carcinoma cells
下载PDF
导出
摘要 目的 :研究细胞因子对肾癌株Fas、FasL表达的影响及其意义。方法 :单独或联合应用IFNγ ,IFNα ,IL 2 ,TNFα刺激肾癌株 786 0、GRC 1细胞并检测Fas、FasL表达 ,以Fas单克隆抗体 (FasAb)诱导其凋亡 ,以JurkatT细胞共培养试验检测其FasL功能。结果 :1 IFNγ、IFNα均能显著上调 786 0、GRC 1细胞的Fas表达 (P <0 0 1,P <0 0 1) ,并促进FasAb诱导的凋亡 (P <0 0 1,P <0 0 1)。 2 TNFα、IFNα能分别上调 786 0、GRC 1细胞的FasL表达。IFNγ能显著上调 786 0、GRC 1细胞的FasL表达(P<0 0 1,P <0 0 1) ,并促进JurkatT细胞凋亡 (P <0 0 1,P <0 0 1)。结论 :IFNγ、IFNα可增强肾癌细胞株的Fas表达 ,并促进FasAb介导的凋亡。但其亦能上调肾癌细胞FasL表达并增强其对淋巴细胞的攻击作用。 Objective:To investigate the role of cytokines in modulating expression of Fas and FasL in renal cell carcinoma cells(RCCs) and its implication.Methods:Combination treatment of 786 0 and GRC 1 cells with cytokines including IFNγ?IFNα,IL 2,TNFα and anti Fas monoclonal antibody (FasAb) to induc apoptosis.FasL function was assessed by coculture assays in vitro using renal cancer cells 786 0 or GRC 1 and Fas sensitive Jurkate T cells.Results:1.Either IFNγ or IFNα could up regulate the Fas expression and subsequently augment the Fas mediated apoptosis in 786 0 and GRC 1 cells.2.IFNγ and IFNα could up regulate the FasL expression in 780 0 and GRC 1 cells.And subsequently augmente the apoptosis of Jurkat T cells cocultured with 786 0 and GRC 1 cells.IFNα had the same effects on 786 0 cells.IFNα had the same effects on GRC 1 cells.Conclusion:IFNγ and IFNα could agument the Fas mediated apoptosis of RCCs by enhancement of Fas expression,but they also up regulate the expression of FasL in RCCs and subsequently augmente the apoptosis of RCCs by enhancment the apoptosis of T lymphocytes by Fas/FasL pathway.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2002年第11期766-768,共3页 Chinese Journal of Immunology
基金 江苏省科学基金资助 (BS983 19)
关键词 细胞因子 肾癌 细胞株 786-0 GRC-1 FAS FASL Renal cell carcinoma Cytokines Fas FasL Apoptosis
  • 相关文献

参考文献8

  • 1郑骏年,谢叔良,陈家存,黄键.Annexin V联合PI染色法定量检测凋亡细胞[J].上海免疫学杂志,1999,19(1):31-34. 被引量:26
  • 2周海胜.TNF相关的凋亡诱导配体及其受体研究进展[J].国外医学(分子生物学分册),2001,23(2):98-100. 被引量:2
  • 3WellerM,Malipiero U,Rensing-Eh1 Aetal. Fas/APO-1 gene transfer for human malignant gliima[ J]. Cancer Res, 1995 ;55:2936
  • 4Xu Xiulong, Fu Xin-Yuan,Plate J et al. IFNγ induce cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression[J]. Cancer Res, 1998;58:2832
  • 5Sayers T J,Brooks A D,Lee J K et al. Molecular mechanism of immunemediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells [J] .J Immunol, 1998; 161:3957
  • 6Niehans G A,Brunner T,Frizelle S P et al. Human lung carcinomas express Fas ligand[J]. Cancer Res, 1997 ;57:1007
  • 7Gratas C,Tohma Y,Bamas C et al. Up-regulation of Fas(APO-1/CD95) ligand and down-regulation if expression in human esophageal cancer[J].Cancer Res, 1998;58:2057
  • 8Naujokat C,Sezer O,Possinger K. Tumor necrosis factor-α and interferon-γ induce expression of functional Fas ligand on HT29 and MCF7 adenocarcino ma cells[J]. Biochem and Biophy Res Com, 1999;264:813

二级参考文献23

  • 1郭爱珍.胸腺细胞的发育与凋亡[J].细胞与分子免疫学杂志,1997,13(2):61-65. 被引量:5
  • 2[6]Nobuhiko K et al.J Exp Med,1999; 189(9):1454
  • 3[7]JeremiasI et al.Eur JImmunol,1998; 28:143
  • 4[8]Nobuhiko K et al.J Immunity,1996; 163:1906
  • 5[9]Janes DB et al.J Biol Chem,1999;274(33):23627
  • 6[10]Halaas O et al.Scand J Immunol,2000; 57(3):244
  • 7[11]Degli-Esposti MA et al.Immunity,1997; 7:815
  • 8[12]Guohua P et al.Science,1997; 276:111
  • 9[13]Walczak H et al.EMBO J,1997;16:5386
  • 10[14]Mariapia A et al.J Exp Med,1997;186(7):1165

共引文献26

同被引文献42

  • 1韩精超,纪志刚,李汉忠.肾癌伴腔静脉瘤栓的诊治进展[J].中国医学科学院学报,2010,32(1):128-131. 被引量:12
  • 2方向明,陈宏伟,陆进,徐平,王卫东,许隽颖,蒋兆贯.术前超选择性肾动脉化疗栓塞对小肾癌保肾手术的价值[J].中国癌症杂志,2006,16(4):301-303. 被引量:6
  • 3王家强,王焱民,李义,孙文涛,谢英林.免疫化疗对肾癌根治术后的远期疗效观察[J].中国生物制品学杂志,2006,19(3):319-320. 被引量:1
  • 4MOI-I M C, ZHANG T, LEE L H, et al. Expression of hepa- CAM is down regulated in cancers and induces senescence- Like growth arrest via a p53/p21-dependent pathway in human breast cancer ceils [J]. Carcinogenesis, 2008, 29 (12): 2298- 2305.
  • 5HE Yun-feng, WU Xiao-hou, LUO Chun-li, et al. Functional significance of the hepaCAM gene in bladder cancer [J]. BioMed Central Cancer, 2010, 10: 83.
  • 6OKEGAWA T, LI Y, PONG R C. Cell adhesion proteins as tu- mor suppressors[J]. Journal of Urology, 2002, 167(4): 1836-1843.
  • 7HELLER G, GERADTS J, ZIEGLER B, et ol. Down regulation of tslcl and dal-1 expression occurs frequently in breast can- cer[J]. Breast Cancer Research and Treatment, 2007, 103(3): 283-291.
  • 8ITO T, SHIMADA Y, HASHIMOTO Y, et al. Involvement of tslcl in progression of esophageal squamous cell carcinoma[J]. Cancer Research, 2003, 63(19): 6320-6326.
  • 9KUNATH T, ORDOIEZ-G C, TURBIDE C, et al. Inhibition of colonic tumor cell growth by biliary glycoprotein[J]. Oncogene,1995, 11(11): 2375-2382.
  • 10HSIEH J T, LUO W, SONG W, et al. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C- CAM) in prostate carcinoma cell revealed by sense and anti- sense approaches[J]. Cancer Research, 1995, 55(1): 190-197.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部